Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for alpha-1 proteinase inhibitor
Most Correlated Studies
- Drug target sets for approved compounds
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
- Broad Connectivity Map (CMAP 2.0) compound database
Most Relevant Literature
- Expert Perspectives on the Management of Alpha 1-Antitrypsin Deficiency.
- Measuring of Alpha-1 Antitrypsin Concentration by Nephelometry or Turbidimetry.
- Alpha-1 Antitrypsin Deficiency.
- Review article: New developments in biomarkers and clinical drug development in alpha-1 antitrypsin …
- Gene therapy for alpha-1 antitrypsin deficiency: an update.
Most Relevant Clinical Trials
- Efficacy and Safety Study of Augmentation Therapy With ARALAST Fraction IV-1 (Human Alpha 1 - Protei…
- Safety and Pharmacokinetics of Alpha-1 Proteinase Inhibitor in Subjects With Alpha1-Antitrypsin Defi…
- Phase II/III Study of an Alpha-1 Proteinase Inhibitor (Kamada-API) in Individuals With Alpha-1 Antit…
- Safety and Tolerability Trial of Inhaled Alpha1-Proteinase Inhibitor (Human), Hydrophobic Chromatogr…
- Efficacy and Safety of Alpha1-Proteinase Inhibitor (Human), Modified Process (Alpha-1 MP) in Subject…
